![<?echo $_SERVER['SERVER_NAME'];?>](/template/twentyseventeen/skin/images/header.jpg)
According to relevant statistics, there are currently more than 800 pharmaceutical machinery enterprises in China and the market scale has reached 15 billion. In addition to meeting the needs of domestic pharmaceutical companies, it is also exported to dozens of countries and regions such as the United States and Japan.
At present, the opportunities we face are no longer simply the traditional opportunities for integrating the global division of labor system, expanding exports, and accelerating investment, but rather forcing us to expand domestic demand, improve innovation capabilities, and promote new opportunities for the transformation of economic development methods. We must make full use of the forceful mechanism of the formation of the international financial crisis and focus on resolving the contradiction of overcapacity.
With the advancement of medical reform work and the implementation of new drug GMP, the scale of the domestic market is expected to double. This is a huge advantage for domestic pharmaceutical machinery companies in need of space for development. But behind the development opportunities, there are defects in the industry.
The rapid development of the pharmaceutical machinery industry in China takes several years to complete the decades of development in developed countries. However, due to the non-standard related standards in the country and low industry barriers, the enterprises are uneven. Some companies not only have low-price vicious competition, but also have frequent quality problems. According to industry insiders, some small- and medium-sized pharmaceutical machinery manufacturers have adopted a price-cutting measure to create a delivery effect, which eventually forced the entire industry to join the ranks of “price-reduction promotion and market-changingâ€.
The production standards in the domestic pharmaceutical industry and related fields are constantly improving, and many have achieved convergence with international standards. This has undoubtedly brought great challenges to domestic pharmaceutical machinery companies.
The sluggish international economic development has seriously affected the development of domestic enterprises. In the face of sluggish external sales, the demand for the domestic market is particularly important. Domestic companies can only expand and expand their domestic market share only if they continue to transform and upgrade their products to the high-end pharmaceutical machinery sector and increase the added value of their products.
fitting injection mold,family injection mold,desktop injection mold,design injection mold
Global Molding Machinery Co., Ltd , https://www.globalinjectionmolds.com